Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bekasi Asri Pemula Tbk (BAPA) vs Tempo Scan Pacific Tbk. (TSPC)

Bekasi Asri Pemula TbkTrading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bekasi Asri Pemula Tbk dan Tempo Scan Pacific Tbk.: Bekasi Asri Pemula Tbk diperdagangkan di Rp149 (kapitalisasi pasar 99,93 M, volume 24 jam 4,16 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.780 (kapitalisasi pasar 12,58 T, volume 24 jam 216,9 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 125,9× kapitalisasi pasar Bekasi Asri Pemula Tbk, dan Bekasi Asri Pemula Tbk lebih aktif diperdagangkan (4,16 jt vs 216,9 rb). Mana yang lebih baik tergantung tujuan investasimu.

BAPATSPC
Kapitalisasi Pasar
99,93 M12,58 T
Volume
4,16 jt216,9 rb
Lot
41,57 rb2,17 rb
Perputaran
621,05 jt599 jt
Harga Rata-rata
149,392.761,65
Nilai Transaksi
621,05 jt599 jt
Harga Ekuilibrium Indikatif
1532.790
Volume Ekuilibrium Indikatif
2,78 rb3,9 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BAPA
Lihat detail
TSPC
Lihat detail

Tentang Bekasi Asri Pemula Tbk

PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.

Selengkapnya di halaman BAPA

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC